Corporate News Update – Tel Aviv Stock Exchange
Formula (FORTY.TA) closed the most recent 24‑hour session up 0.99 %, reaching ILA 36,380 at 08:49 AM CET on Wednesday, 21 March 2026. The share price is currently buoyant, reflecting a steady upward trajectory of 2.48 % since the close of last month.
Key Metrics
- Shares Outstanding: 153.2 k
- Market Capitalisation: ILA 1.8 bn
- 24‑Hour Trading Volume: ILA 884 mn
- Simple Moving Average (200 days): ILA 38,293.5
- 52‑Week High: ILA 58,250 (10 December 2025)
- 52‑Week Low: ILA 29,620 (29 June 2026)
The recent gain places Formula comfortably above its 200‑day SMA, signalling a positive trend that aligns with the broader market rally in the Tel Aviv technology sector. The liquidity remains solid, with a daily volume of ILA 884 mn underscoring investor confidence.
Peer Performance (Last 24 Hours)
| Ticker | % Move | Current Price | Market Cap |
|---|---|---|---|
| Parazero (PRZO) | +0.95 % | USD 0.52 | USD 15.3 mn |
| Quoin Lt (QNRX) | +2.05 % | USD 4.04 | USD 18.7 mn |
| Pulsenmore (PLSM) | –4.81 % | USD 1.76 | USD 12.2 mn |
| Cellcom Israel (CEL.TA) | –0.5 % | ILA 3,493 | ILA 1.9 bn |
| Hilan (HLAN.TA) | –1.28 % | ILA 24,730 | ILA 1.8 bn |
While Formula’s performance eclipses that of several peers, it remains competitive relative to industry benchmarks. The modest decline in Cellcom Israel and Hilan suggests a sector‑wide rotation toward newer high‑growth names, a trend that Formula is well positioned to capture.
Forward‑Looking Insight
Formula Systems 1985 Ltd. has consistently expanded its footprint across high‑growth verticals—telecommunications, banking, insurance, public utilities, airports, travel, and retail—by delivering tailored software consulting and integrated business solutions. The firm’s IPO in 1997 and subsequent market evolution demonstrate a resilience that is now reflected in its current valuation.
Given the company’s robust pipeline and strategic positioning in sectors that are increasingly digital‑centric, we anticipate continued upward pressure on shares. The alignment of Formula’s recent performance with the 200‑day SMA, coupled with a favourable P/E relative to peers, signals potential for further upside as the market digests its long‑term growth narrative.
Investors should monitor the upcoming earnings cycle and any strategic announcements, particularly regarding new client acquisitions or technology deployments, which could further solidify Formula’s standing in the Tel Aviv market.
